These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6163343)

  • 21. Radioimmunoassay for prostatic acid phosphatase helps discriminate patients with prostatic cancer.
    Blick KE; Dick TT; Webb TA
    Clin Chem; 1982 Dec; 28(12):2373-7. PubMed ID: 6183027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoreactive prostate-specific acid phosphatase in prostatic cancer.
    Kontturi M; Vihko P; Lukkarinen O; Vihko R
    Scand J Clin Lab Invest Suppl; 1985; 179():67-74. PubMed ID: 3866311
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostatic acid phosphatase by radioimmunoassay. Sensitivity compared with enzymatic assay.
    Lindholm GR; Stirton S; Liedtke RJ; Batjer JD
    JAMA; 1980 Nov; 244(18):2071-3. PubMed ID: 6159488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
    Fleischmann J; Catalona WJ; Fair WR; Heston WD; Menon M
    J Urol; 1983 Feb; 129(2):312-4. PubMed ID: 6187945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum acid phosphatase levels in untreated carcinoma patients.
    Ho E; Mehan DJ
    Mo Med; 1975 Jun; 72(6):289-90. PubMed ID: 1143260
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum and bone marrow radioimmunoassay of acid phosphatase in prostatic cancer.
    Sarosdy MF; Kledzik G; Lamm DL
    Urology; 1982 Jan; 19(1):33-6. PubMed ID: 6173949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.
    Morote Robles J; Ruibal Morell A; Palou Redorta J; de Torres Mateos JA; Soler Roselló A
    Eur Urol; 1988; 14(5):360-6. PubMed ID: 2458936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
    Salo JO; Rannikko S; Haapiainen R
    Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens.
    Kuriyama M; Wang MC; Lee CL; Killian CS; Papsidero LD; Inaji H; Loor RM; Lin MF; Nishiura T; Slack NH; Murphy GP; Chu TM
    J Natl Cancer Inst; 1982 Jan; 68(1):99-105. PubMed ID: 6172628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A critical evaluation of a specific radioimmunoassay for prostatic acid phosphatase.
    Goldenberg SL; Silver HK; Sullivan LD; Morse MJ; Archibald EL
    Cancer; 1982 Nov; 50(9):1847-51. PubMed ID: 7116309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of tumor markers in the diagnosis of prostatic cancer].
    Casas Terrón E; Mari Ruiz M; Molina Andreu E
    Arch Esp Urol; 1993 Mar; 46(2):99-103. PubMed ID: 7684585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolytic split products (FSP) and ethanol gelation test in preoperative evaluation of patients with prostatic disease.
    Mertens BF; Greene LF; Bowie EJ; Elveback LR; Owen CA
    Mayo Clin Proc; 1974 Sep; 49(9):642-6. PubMed ID: 4137666
    [No Abstract]   [Full Text] [Related]  

  • 33. [Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience].
    Mannini D; Aiello E; Maver P; Corrado G; Vecchi F; Bellanova B
    Minerva Urol Nefrol; 1987; 39(4):335-41. PubMed ID: 2453928
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical evaluation of immunological methods for detection for serum prostatic acid phosphatase.
    Pontes JE; Choe BK; Rose NR; Ercole C; Pierce JM
    J Urol; 1981 Sep; 126(3):363-5. PubMed ID: 6168779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)].
    Tellier JL; Chatal JF; Bourdin S; Auvigne J; Etienne P; Faye R
    J Urol (Paris); 1981; 87(3):169-73. PubMed ID: 7240777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Radioimmunoassay kit for human prostate acid phosphatase--experimental and clinical evaluation of RIA-Quant P.A.P. Test Kit].
    Wakabayashi K; Sugiyama Y; Takahashi E; Shida K
    Kaku Igaku; 1982 Apr; 19(3):467-75. PubMed ID: 6182321
    [No Abstract]   [Full Text] [Related]  

  • 37. Radioimmunoassay for prostatic acid phosphatase in early prostatic carcinoma.
    Samuell CT; Morgans BT; O'Donoghue EP
    Br J Urol; 1984 Apr; 56(2):208-12. PubMed ID: 6498440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostatic acid phosphatase: comparison of radioimmunoassay and enzyme activity assay.
    Mensink HJ; Marrink J; Hindriks FR; van Zanten AK
    J Urol; 1983 Jun; 129(6):1136-40. PubMed ID: 6854787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
    Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
    Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.